← Leaderboards
Romina Mizrahi
Centre For Addiction And Mental Health
$5,182,194
Attributed
$5,182,194
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $790.4K · FY2014–25$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,182,194 · 4
By mechanism
R01$4,888,487 · 3
R21$293,707 · 1
Top collaborators
No co-investigators on record.
Most similar at Centre For Addiction And Mental Health
Same institution · by research overlap
- Isabelle Boileau$1,005,010
- Alan Alexander Wilson$426,476
- Clement Hamani$307,256
- Monica Malta$339,158
- Mindaugas Å Telemäkas$1,100,181
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularImageComplexBrainResolutionTissuesPrefrontal CortexIn VivoPositron-Emission TomographyHealthy VolunteerPreventionRadiotracerPropertyFutureLifeFunctional DisorderPsychopathologyNew Therapeutic TargetPsychotic SymptomsAntipsychotic AgentsCognitive DeficitsNeurobiologyRadioligandScanning
Grant awards (16)
Imaging Alterations in Endocannabinoid Metabolism in Depression and Suicide$539,383
R01 · FY2025 · MH · contact PI
Imaging Alterations in Endocannabinoid Metabolism in Depression and Suicide$539,336
R01 · FY2024 · MH · contact PI
Imaging Alterations in Endocannabinoid Metabolism in Clinical High Risk and First Episode Psychosis$443,649
R01 · FY2022 · MH · contact PI
Imaging Alterations in Endocannabinoid Metabolism in Clinical High Risk and First Episode Psychosis$1
R01 · FY2022 · MH · contact PI
Imaging Alterations in Endocannabinoid Metabolism in Clinical High Risk and First Episode Psychosis$443,650
R01 · FY2020 · MH · contact PI
Imaging Alterations in Endocannabinoid Metabolism in Clinical High Risk and First Episode Psychosis$443,650
R01 · FY2019 · MH · contact PI
Imaging Alterations in Endocannabinoid Metabolism in Clinical High Risk and First Episode Psychosis$443,650
R01 · FY2018 · MH · contact PI
Imaging Neuroinflammation in Clinical high risk and Schizophrenia$327,982
R01 · FY2018 · MH · contact PI
Imaging Alterations in Endocannabinoid Metabolism in Clinical High Risk and First Episode Psychosis$462,413
R01 · FY2017 · MH · contact PI
Imaging Neuroinflammation in Clinical high risk and Schizophrenia$327,982
R01 · FY2017 · MH · contact PI
Imaging Neuroinflammation in Clinical high risk and Schizophrenia$327,039
R01 · FY2016 · MH · contact PI
Imaging Neuroinflammation in Clinical high risk and Schizophrenia$262,032
R01 · FY2015 · MH · contact PI
Imaging Alterations in Endocannabinoid Metabolism in Schizophrenia$147,075
R21 · FY2015 · MH · contact PI
Imaging Neuroinflammation in Clinical high risk and Schizophrenia$65,002
R01 · FY2015 · MH · contact PI
Imaging Neuroinflammation in Clinical high risk and Schizophrenia$262,718
R01 · FY2014 · MH · contact PI
Imaging Alterations in Endocannabinoid Metabolism in Schizophrenia$146,632
R21 · FY2014 · MH · contact PI